0001061983-21-000265.txt : 20211223 0001061983-21-000265.hdr.sgml : 20211223 20211223191104 ACCESSION NUMBER: 0001061983-21-000265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211223 FILED AS OF DATE: 20211223 DATE AS OF CHANGE: 20211223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaye Edward M. MD CENTRAL INDEX KEY: 0001522780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 211518563 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-12-23 0 0001061983 CYTOKINETICS INC CYTK 0001522780 Kaye Edward M. MD 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2021-12-23 4 M 0 15000 7.61 A 21765 D Common Stock 2021-12-23 4 S 0 15000 45.0 D 6765 D Non-Qualified Stock Option (right to buy) 7.61 2021-12-23 4 M 0 15000 0.0 D 2016-06-18 2026-05-18 Common Stock 15000 0 D Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021. Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. By: Robert Wong For: Edward M. Kaye 2021-12-23